中西医结合治疗肺原性心脏病急性发作期62例疗效观察

Therapeutic effect the combination of traditional Chinese medicine with western medicine on 62 patients with pulmorary heart disease at acute attack stage

目的观察中西医结合治疗肺原性心脏病急性发作期的临床疗效。方法 1 1 3例肺原性心脏病急性发作期患者随机分为 2组。对照组 5 1例 ,西医常规治疗 ;治疗组 62例 ,在对照组治疗的基础上加用黄芪注射液、川芎嗪注射液、鱼腥草注射液 ,静脉点滴 ,每日 1次。 2组均 1 0日为 1个疗程。结果治疗组总有效率为 93.5 4 % ,对照组为 70 .49% ,2组比较有显著性差异 (P <0 .0 5 )。治疗组治疗后全血比黏度、血浆黏度、纤维蛋白原较治疗前均显著改善 (P均 <0 .0 1 ) ,红细胞聚集指数、红细胞压积较治疗前亦均明显改善 (P均 <0 .0 5 ) ,较对照组治疗后全血比黏度、血浆黏度、红细胞聚集指数、纤维蛋白原均有显著性差异 (P均 <0 .0 5或P <0 .0 1 )。

To observe the clinical efficacy of the combination of traditional Chinese medicine with western medicine on pulmorary heart disease at acute attack stage.Methods 113 patients with pulmorary heart disease were randomly divided into two groups. 52 patients in cortrol group were treated by routine western medicine; 62 patients in treatment group,based on the treatment in control group, were treated with Astragalus membranaceus injection,Houttuynia cordata injection and Tetramethylpyrazine injection,infused by intravenous drip ,once a day, with a treatment course of ten days for both groups.Results The total effective rate was 93.54% in treatment group,and 70.49% in control group,there was significant difference between the two groups.The whole blood viscosity, plasma viscosity and fibrinogen were improved significantly after treatment in treatment group (P<0.01), as well the RBC agrregation index and hematokrit (P<0.05), there were significant differences between the two groups(P<0.05 or P<0. 01) . Conclusion The combination of traditional Chinese medicine with western medicine is effctive in treating pulmorary heart disease.